Application
Western blot analysis of extracts from Jurkat cells, using BORG3 Antibody. The lane on the right is treated with the synthesized peptide.| Product Name | BORG3 antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Product description | Rabbit polyclonal antibody to BORG3Probably involved in the organization of the actin cytoskeleton. May act downstream of CDC42 to induce actin filament assembly leading to cell shape changes. Induces pseudopodia formation in fibroblasts. Inhibits MAPK8 independently of CDC42 binding. Controls septin organization and this effect is negatively regulated by CDC42. |
| Immunogen | The antiserum was produced against synthesized peptide derived from human BORG3. |
| Clonality | Polyclonal |
|---|---|
| Host Species | Rabbit |
| Tested Applications | ELISAWB |
| ELISA: 1:40000Optimal dilutions should be determined experimentally by the end user.: |
|
| Species Reactivity | HumanMouse |
| Concentration | 1mg/ml |
| Purification | Affinity purified |
| Gene Synonyms | Cdc42 effector protein 5 Binder of Rho GTPases 3 Binder of Rho GTPases3 BORG3 Cdc42 effector protein5 |
|---|---|
| Target | BORG3 |
| Molecular Weight(MW) | 15 kDa (note) |
| Tissue Specificity | BORG3 Antibody detects endogenous levels of total BORG3 protein. |
Application
Western blot analysis of extracts from Jurkat cells, using BORG3 Antibody. The lane on the right is treated with the synthesized peptide.| Application Notes | ELISA: 1:40000Optimal dilutions should be determined experimentally by the end user.: |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | Store at -20 degrees Celcius. Product is stable for at least 1 year. |
| Storage Buffer | Phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
